Graminex completes study on pollen extract for women's urinary health

Published: 2-Aug-2022

The randomised, double-blind, placebo-controlled study on 190 women has been completed with positive results

Graminex has completed a clinical study on its Graminex Flower Pollen Extract for women’s urinary incontinence and urinary health with positive results. This study was conducted as a randomised, double-blind, placebo-controlled, study to investigate the effectiveness of Graminex Flower Pollen Extracts in 190 healthy women with urinary incontinence.

Preliminary analysis indicated significant improvements were found in the Graminex® Flower Pollen Extract study group for multiple urinary incontinence quality of life indicators.

There are a large number of women experiencing reduced quality of life due urinary incontinence

For many years flower pollen extracts have been studied for women’s menopause symptoms. Recently, Graminex has discovered benefits in the more specific women’s health category of urinary incontinence, particularly stress-induced urgency. Urinary incontinence is more pronounced in postpartum women as well as during menopause.

“There are a large number of women experiencing reduced quality of life due urinary incontinence. With these study results, Graminex is excited to present a natural alternative to help improve women’s lives during a time when it is needed most,” said Colleen May, CBO.

You may also like